Impax Labs stock surges 4.4% on FDA approval of generic kidney disease medication Renvela

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 24, 2017 at 9:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3